Nukkleus Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q2 2023.
-
Location
-
Jersey City, NJ
-
Fiscal year end
-
30 September
-
Latest financial report
-
14 Aug 2023
Quick Takeaways
- Nukkleus Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q2 2023.
- Headline metric: Return On Equity -75%.
What Changed
- Return On Equity YoY change: <span class="text-green-600">+41%</span>.
- Most recent SEC facts end date: 30 Jun 2023.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2023-06-30) highlights Return On Equity -75.0%, Return On Assets -50.5%, and Operating Margin -39.6%.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
23.9/100
Weak
Confidence medium
Return On Equity
-75%
Metric score 0.0/100
Return On Assets
-50%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.33x
- Debt to Equity
- 0.91x
Strengths
No strong signals yet.
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
-75%
YoY: +41%
Industry median:
0.94%
(n=58)
View history
Return On Assets
-50%
YoY: +44%
Industry median:
-5.1%
(n=56)
View history
Operating Margin
-40%
YoY: +28%
Industry median:
1.4%
(n=41)
View history
Current Ratio
0.33x
YoY: +50%
Industry median:
0.84x
(n=55)
View history
Debt-to-equity
0.91x
YoY: +154%
Industry median:
0.21x
(n=47)
View history
Revenues YoY
11%
YoY:
Industry median:
3.7%
(n=43)
View history
NetIncomeLoss YoY
-38%
YoY:
Industry median:
3.2%
(n=54)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-75%
|
+41%
|
0.94%
(n=58)
|
Q2 2023
|
|
%
|
|
Return On Assets
|
-50%
|
+44%
|
-5.1%
(n=56)
|
Q2 2023
|
Q3 2023
|
%
|
|
Operating Margin
|
-40%
|
+28%
|
1.4%
(n=41)
|
Q2 2023
|
Q3 2023
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0.33x
|
+50%
|
0.84x
(n=55)
|
Q2 2023
|
Q3 2023
|
x
|
|
Debt-to-equity
|
0.91x
|
+154%
|
0.21x
(n=47)
|
Q2 2023
|
Q3 2023
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Revenues YoY
|
11%
|
|
3.7%
(n=43)
|
Q2 2023
|
Q3 2023
|
%
|
|
NetIncomeLoss YoY
|
-38%
|
|
3.2%
(n=54)
|
Q2 2023
|
Q3 2023
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
367,175,886
|
0%
|
Q2 2023
|
Q2 2023
|
shares
|
|
Common Stock, Shares, Outstanding
|
367,175,886
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
|
Common Stock, Value, Issued
|
$36,718
|
0%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
367,175,886
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
367,175,886
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Cost of Revenue
|
$22,299,630
|
+5.1%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Operating Income (Loss)
|
$8,846,148
|
-42%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Nonoperating Income (Expense)
|
$291,084
|
|
Q2 2023
|
Q3 2023
|
USD
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
$9,137,232
|
+39%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Earnings Per Share, Basic
|
0
|
+50%
|
Q2 2023
|
Q3 2023
|
USD/shares
|
|
Earnings Per Share, Diluted
|
0
|
|
Q2 2023
|
Q3 2023
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$142,341
|
+515%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Other Assets, Current
|
$52,703
|
+470%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Assets, Current
|
$2,405,857
|
+147%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Assets
|
$15,346,878
|
-26%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Accounts Payable, Current
|
$106,779
|
+32%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Accrued Liabilities, Current
|
$19,181
|
-96%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Liabilities, Current
|
$7,360,966
|
+65%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Liabilities
|
$7,360,966
|
+65%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Accumulated Other Comprehensive Income (Loss), Net of Tax
|
$6,656
|
|
Q2 2023
|
Q3 2023
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$17,490,131
|
-109%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$7,985,912
|
-51%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Liabilities and Equity
|
$15,346,878
|
-26%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Common Stock, Shares Authorized
|
900,000,000
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
|
Common Stock, Shares, Issued
|
367,175,886
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0
|
0%
|
Q2 2023
|
Q3 2023
|
USD/shares
|
|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
|
$9,177,647
|
-39%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Shares Issued
|
0
|
|
Q2 2023
|
Q3 2023
|
shares
|
|
Preferred Stock, Shares Authorized
|
15,000,000
|
0%
|
Q2 2023
|
Q3 2023
|
shares
|
|
Additional Paid in Capital
|
$25,432,669
|
+3.2%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Shares Outstanding
|
0
|
|
Q2 2023
|
Q3 2023
|
shares
|
|
Amortization of Intangible Assets
|
$66,291
|
0%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Depreciation, Depletion and Amortization
|
$2,371,566
|
0%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Share-based Payment Arrangement, Expense
|
$693,149
|
-86%
|
Q2 2023
|
Q3 2023
|
USD
|
|
Preferred Stock, Par or Stated Value Per Share
|
0
|
0%
|
Q2 2023
|
Q3 2023
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets